|
|
Volumn 132, Issue 1 II, 1996, Pages 235-243
|
|
Angiotensin-converting enzyme inhibition after myocardial infarction: The Trandolapril Cardiac Evaluation study
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
TRANDOLAPRIL;
ANTIHYPERTENSIVE AGENT;
INDOLE DERIVATIVE;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CORONARY RISK;
DOSE RESPONSE;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
FEMALE;
HEART INFARCTION;
HEART LEFT VENTRICLE FAILURE;
HEART LEFT VENTRICLE FUNCTION;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
MORTALITY;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
RISK ASSESSMENT;
AGED;
ARTICLE;
CONGESTIVE HEART FAILURE;
EUROPE;
MIDDLE AGED;
MULTICENTER STUDY;
SUDDEN DEATH;
AGED;
ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
ANTIHYPERTENSIVE AGENTS;
DEATH, SUDDEN, CARDIAC;
DOUBLE-BLIND METHOD;
EUROPE;
FEMALE;
HEART FAILURE, CONGESTIVE;
HUMANS;
INDOLES;
MALE;
MIDDLE AGED;
MYOCARDIAL INFARCTION;
VENTRICULAR DYSFUNCTION, LEFT;
|
|
EID: 0029951579
PISSN: 00028703
EISSN: None
Source Type: Journal
DOI: 10.1016/S0002-8703(96)90559-1 Document Type: Conference Paper |
|
Times cited : (41)
|
|
References (0)
|
